Bayesian Capital Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,816
Closed -$771K 455
2025
Q3
$771K Sell
2,816
-14,500
-84% -$3.96M 0.16% 203
2025
Q2
$4.47M Buy
+17,316
New +$4.13M 0.71% 21
2025
Q1
Sell
-22,100
Closed -$5.05M 915
2024
Q4
$5.05M Buy
22,100
+14,300
+183% +$3.44M 0.62% 25
2024
Q3
$1.9M Sell
7,800
-6,365
-45% -$1.42M 0.22% 133
2024
Q2
$2.71M Buy
14,165
+5,200
+58% +$1.06M 0.31% 80
2024
Q1
$1.78M Buy
8,965
+4,700
+110% +$861K 0.17% 171
2023
Q4
$734K Buy
+4,265
New +$655K 0.08% 293
2023
Q2
Sell
-1,772
Closed -$388K 1023
2023
Q1
$388K Buy
+1,772
New +$384K 0.05% 456
2022
Q4
Sell
-2,487
Closed -$543K 996
2022
Q3
$543K Buy
2,487
+1,400
+129% +$319K 0.11% 261
2022
Q2
$228K Buy
+1,087
New +$231K 0.04% 584
2021
Q3
Sell
-1,441
Closed -$355K 505
2021
Q2
$355K Buy
+1,441
New +$303K 0.09% 238
2020
Q4
Sell
-2,700
Closed -$463K 640
2020
Q3
$463K Sell
2,700
-3,258
-55% -$602K 0.11% 240
2020
Q2
$1.14M Sell
5,958
-3,240
-35% -$530K 0.25% 108
2020
Q1
$1.35M Sell
9,198
-16,400
-64% -$2.61M 0.29% 77
2019
Q4
$3.97M Buy
25,598
+5,900
+30% +$850K 0.68% 16
2019
Q3
$2.66M Buy
+19,698
New +$2.58M 0.5% 41
2018
Q3
Sell
-11,874
Closed -$1.23M 770
2018
Q2
$1.23M Buy
11,874
+1,300
+12% +$132K 0.28% 92
2018
Q1
$1.04M Sell
10,574
-4,100
-28% -$387K 0.26% 113
2017
Q4
$1.24M Buy
+14,674
New +$1.21M 0.25% 127
2017
Q2
Sell
-6,674
Closed -$480K 570
2017
Q1
$480K Buy
+6,674
New +$461K 0.23% 172
2016
Q4
Sell
-11,974
Closed -$776K 688
2016
Q3
$776K Buy
+11,974
New +$797K 0.51% 50
2016
Q2
Sell
-7,374
Closed -$426K 522
2016
Q1
$426K Buy
+7,374
New +$417K 0.4% 69

Other funds holding RMD